Literature DB >> 22987246

Will GM animals follow the GM plant fate?

Núria Vàzquez-Salat1, Louis-Marie Houdebine.   

Abstract

Despite being both Genetically Modified Organisms (GMOs), GM plants and GM animals share few similarities outside the laboratory premises. Whilst GM plants were soon embraced by industry and became a commercial success, only recently have GM animals reached the market. However, an area where GM animals are likely to follow the GM plant path is on their potential to cause social unrest. One of the major flaws of the 90s GMO crisis was the underestimation of the influence that different players can have in the adoption of new biotechnological applications. In this article we describe the unique evolution of GM animals in two of the most important fields: the pharmaceutical and the breeding sectors. For our analysis, we have subdivided the production chain into three governance domains: Science, Market and Public. We describe the influence and interaction of each of these domains as a vehicle for predicting the future adoptability of GM animals and to highlight conflicting areas.

Entities:  

Mesh:

Year:  2012        PMID: 22987246     DOI: 10.1007/s11248-012-9648-5

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  12 in total

1.  Who is driving biotechnology acceptance?

Authors:  Nicholas Kalaitzandonakes; Jos Bijman
Journal:  Nat Biotechnol       Date:  2003-04       Impact factor: 54.908

Review 2.  The current state of GMO governance: are we ready for GM animals?

Authors:  Núria Vàzquez-Salat; Brian Salter; Greet Smets; Louis-Marie Houdebine
Journal:  Biotechnol Adv       Date:  2012-02-15       Impact factor: 14.227

3.  The farmyard drug store.

Authors: 
Journal:  Nature       Date:  2006-09-07       Impact factor: 49.962

Review 4.  Animal pharming, two decades on.

Authors:  Alexander Kind; Angelika Schnieke
Journal:  Transgenic Res       Date:  2008-07-29       Impact factor: 2.788

5.  Barnyard biotech--lame duck or golden goose?

Authors:  Kendall Powell
Journal:  Nat Biotechnol       Date:  2003-09       Impact factor: 54.908

6.  Enzyme therapy for pompe disease with recombinant human alpha-glucosidase from rabbit milk.

Authors:  J M Van den Hout; A J Reuser; J B de Klerk; W F Arts; J A Smeitink; A T Van der Ploeg
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

7.  Production of transgenic rabbits, sheep and pigs by microinjection.

Authors:  R E Hammer; V G Pursel; C E Rexroad; R J Wall; D J Bolt; K M Ebert; R D Palmiter; R L Brinster
Journal:  Nature       Date:  1985 Jun 20-26       Impact factor: 49.962

8.  Is there a risk from not using GE animals?

Authors:  James D Murray; Elizabeth A Maga
Journal:  Transgenic Res       Date:  2009-11-04       Impact factor: 2.788

Review 9.  Biosafety and risk assessment framework for selectable marker genes in transgenic crop plants: a case of the science not supporting the politics.

Authors:  Koreen Ramessar; Ariadna Peremarti; Sonia Gómez-Galera; Shaista Naqvi; Marian Moralejo; Pilar Muñoz; Teresa Capell; Paul Christou
Journal:  Transgenic Res       Date:  2007-04-14       Impact factor: 3.145

Review 10.  Genetically modified crops for the bioeconomy: meeting public and regulatory expectations.

Authors:  Saharah Moon Chapotin; Jeffrey D Wolt
Journal:  Transgenic Res       Date:  2007-08-14       Impact factor: 3.145

View more
  4 in total

1.  Society and GMOs--chicken and egg? The lessons from the GM crops debate in Europe over risk management and communication provide valuable pointers for the upcoming debate on GM animals.

Authors:  Núria Vàzquez-Salat; Louis-Marie Houdebine
Journal:  EMBO Rep       Date:  2013-07-16       Impact factor: 8.807

Review 2.  Strategies to enable the adoption of animal biotechnology to sustainably improve global food safety and security.

Authors:  Mark Tizard; Eric Hallerman; Scott Fahrenkrug; Martina Newell-McGloughlin; John Gibson; Frans de Loos; Stefan Wagner; Götz Laible; Jae Yong Han; Michael D'Occhio; Lisa Kelly; John Lowenthal; Kari Gobius; Primal Silva; Caitlin Cooper; Tim Doran
Journal:  Transgenic Res       Date:  2016-05-31       Impact factor: 2.788

Review 3.  Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic molecules.

Authors:  Isabelle Legastelois; Sophie Buffin; Isabelle Peubez; Charlotte Mignon; Régis Sodoyer; Bettina Werle
Journal:  Hum Vaccin Immunother       Date:  2016-12-01       Impact factor: 3.452

Review 4.  Novel GM animal technologies and their governance.

Authors:  Ann Bruce; David Castle; Corrina Gibbs; Joyce Tait; C Bruce A Whitelaw
Journal:  Transgenic Res       Date:  2013-06-19       Impact factor: 2.788

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.